Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2009 Results
Date:11/2/2009

oncentrating its efforts on the transition of the commercialization and development rights to Fanapt(TM) in the U.S. and Canada to Novartis and expects to work closely on the joint steering committee to assist in the anticipated commercial launch of Fanapt(TM) in the first quarter of 2010. The transition includes all regulatory, manufacturing and post-marketing commitments requested by the FDA. Under the terms of the agreement with Novartis, except for two small post-approval studies started by Vanda prior to the execution date of the agreement, which Vanda is obligated to complete, Novartis will be responsible for the further clinical development activities in the U.S. and Canada, including the development and commercialization of a depot formulation of Fanapt(TM). In addition, the Company will also evaluate the regulatory path and commercial opportunity for Fanapt(TM) outside the U.S. and Canada. Vanda will also continue the clinical, regulatory and commercial evaluation for tasimelteon. The Company intends to operate on a reduced spending plan with its fixed overhead costs expected to be approximately $2.5 million to $3 million per quarter.

CONFERENCE CALL

Vanda has scheduled a conference call for today, Monday, November 2, 2009, at 10:00 AM ET. During the call, Mihael H. Polymeropoulos, M.D., President and CEO, and Stephanie Irish, Acting CFO, will discuss quarterly results and other corporate activities. Investors can call 1-800-901-5247 (domestic) and 1-617-786-4501 (international) prior to the 10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos (participant passcode 46702701). A replay of the call will be available Monday, November 2, 2009, at 1:00 PM ET and will be accessible until Monday, November 9, 2009, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 87052099. '/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
2. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
3. Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
4. Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
5. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
6. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
7. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
8. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
9. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
10. Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
11. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... PA (PRWEB) September 21, 2014 "I ... their legs and back but haven’t the money for ... I’d like to have such a product for myself." ... effective way to stretch the thigh muscles and align ... as well as relieves discomfort of pinched nerves. Compact ...
(Date:9/21/2014)... Best Cheap Hosting USA, one of ... Bluehost and GreenGeeks are the best Reseller hosting suppliers ... reseller hosting supplier. Actually, these companies have outperformed their ... support. People can get the best web hosting at ... According to the manager, reseller hosting is a very ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 To accommodate ... e-powered platform and provide more trendy items. Recently, the ... . By offering the new and elegant wedding gowns, ... get what they need in an easy way. Its ... deeply discounted rates, from 12% off to 62% off. ...
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... C8 lawsuits move forward in the ... list of 20 possible C8 lawsuits selected for ... reports Wright & Schulte LLC. Court records show these ... C8 lawsuits filed that represent individuals who purportedly developed ... result of being exposed to water contaminated by the ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4
... Washington Teenage girls are setting new trends in drug ... , a report has shown. ,Teen boys have ... Wanting a slice of the vice, teen girls have become ... drugs, according to the White House Office of National Drug ...
... finds that sleep deprivation can adversely affect a persons ... of gains and making light of ones losses ... neural underpinnings of risky decision making under conditions of ... studied healthy volunteers as they underwent functional magnetic resonance ...
... not get training posts through the flawed Medical Training ... government is stalling on a new contract for ... figures show that 34,250 doctors are chasing 18,500 specialist ... far given no commitment that trainee doctors will be ...
... definite link between pregnancy, migraine and stroke, US researchers ... one. ,In fact, Cheryl Bushnell, assistant professor ... Disease in Durham, explained that pregnant women who suffered ... than pregnant women who did not suffer migraine. ...
... Science & Technology, Government of India and the ... today to address a major obstacle in AIDS ... elicit neutralizing antibodies against HIV. A new Indian ... and the Department of Biotechnology, will comprise top ...
... disturbing link between Reclast, made by Novartis AG and Fosamax manufactured ... in a small number of women users. Both are known bone-building ... more pronounced with Reclast, given as an annual shot. But there ... took the leading osteoporosis pill, Fosamax by Merck & Co. They ...
Cached Medicine News:Health News:Sleep Deprivation can Affect Competent Decision-making 2Health News:Junior Doctors Facing More Misery Because of Contract Deadlock: BMA 2Health News:DBT And IAVI Forge Partnership To Develop Next Generation Vaccine Candidates 2Health News:DBT And IAVI Forge Partnership To Develop Next Generation Vaccine Candidates 3Health News:Anti-osteoporosis Drugs Could Result in Irregular Heart Rhythm, New Study 2
(Date:9/19/2014)... , Sept. 19, 2014 Medical science ... relationships with key opinion leaders (KOLs) who can ... Despite the critical nature of the MSL function, ... including altering the landscape for creating and maintaining ... to research, the oversight responsibility for the MSL ...
(Date:9/19/2014)... 2014  Today DePuy Synthes Companies of Johnson ... systems featuring its proprietary variable angle locking technology. ... to match patient anatomy and fracture pattern and ... systems are being introduced in conjunction with the ... the International Federation of Foot & Ankle Societies ...
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- ... Oxybutynin Hydrochloride Industry, 2009-2019 is a professional ... Chinese Oxybutynin Hydrochloride industry. The report firstly ... including its classification, application and manufacturing technology. ... top manufacturers of Oxybutynin Hydrochloride listing their ...
Breaking Medicine Technology:Role of Medical Science Liaisons Shifting in Healthcare Industry 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5
... Sept. 21, 2011 Mylan Inc. (Nasdaq: ... a settlement and license agreement with Hoffman La Roche ... and 500 mg, USP, known generically as Capecitabine Tablets. ... in the treatment of metastatic breast and colorectal cancers. ...
... At Home Healthcare, a leading provider of home ... with Cardiocom to provide advanced home telehealth technology to ... a world class developer, manufacturer and clinical service provider ... to provide superior home care and to ensure the ...
Cached Medicine Technology:Mylan Announces XELODA® Settlement and License Agreement 2At Home Healthcare Expands Telehealth Program With Cardiocom® Telehealth Technology 2
Alexander periosteal elevators....
Lambotte periosteal elevators....
Cottle periosteal & skin elevator, 7 1/2", slightly curved blade, 9 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: